Mitochondrial dysfunction following perinatal exposure to nucleoside analogues
Microarray analysis during adipogenesis identifies new genes altered by antiretroviral drugs
Antiretroviral resistance in viral isolates from HIV-1-transmitting mothers and their infants
Impaired in-vitro growth of megakaryocytic colonies derived from CD34 cells of HIV-1-infected patients with active viral replication
Short-term antiviral activity of TMC278 – a novel NNRTI – in treatment-naive HIV-1-infected subjects
Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART
Placental transfer and pharmacokinetics of lopinavir and other protease inhibitors in combination with nevirapine at delivery
Examining the production costs of antiretroviral drugs
Cost-effectiveness of HIV post-exposure prophylaxis in France
Domestic violence and prevention of mother-to-child transmission of HIV-1
Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-year prospective cohort study
Mitochondrial dysfunction: prevention of HIV-1 mother-to-infant transmission outweighs fear
IL-1 gene polymorphism and periodontal status of HIV Brazilians on highly active antiretroviral therapy
Sexual risk behaviour among HIV-positive individuals in clinical care in urban KwaZulu-Natal, South Africa
Transmission of HIV-1 from an obstetrician to a patient during a caesarean section
Response to Mallolas et al. ‘Obstetrician-to-patient HIV transmission’
Acute renal failure in HIV patients with liver cirrhosis receiving tenofovir: a report of two cases
The epidemic of HIV-associated tuberculosis in sub-Saharan Africa: does this also impact non-HIV-infected individuals?
Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G
Virologic, immunologic, and clinical benefits from early combined antiretroviral therapy in infants with perinatal HIV-1 infection
Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy in Botswana